COÖPERATIE AVEBE U.A. – Trademark Portfolio
Entity Type: 99
COÖPERATIE AVEBE U.A. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include PREJEL, PASELLI, AMYLOFAX, PROTAMYL, and PROTASTAR. The owner is based in 9607 PT FOXHOL.
AVEBE-Weg 1
9607 PT FOXHOL , NL
Showing of trademarks Trademarks
Trademark Classifications
COÖPERATIE AVEBE U.A.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does COÖPERATIE AVEBE U.A. have?
COÖPERATIE AVEBE U.A. has 12 U.S. trademarks filed with the USPTO. Of these, 6 registered, 6 cancelled.
What trademark classes does COÖPERATIE AVEBE U.A. file in?
COÖPERATIE AVEBE U.A. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 30 (Staple Foods), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are COÖPERATIE AVEBE U.A.'s most well-known trademarks?
COÖPERATIE AVEBE U.A.'s registered trademark portfolio includes well-known marks such as PREJEL, PASELLI, AMYLOFAX, PROTAMYL, and PROTASTAR. These are among 6 currently registered trademarks in the portfolio.
What is COÖPERATIE AVEBE U.A.'s trademark registration success rate?
COÖPERATIE AVEBE U.A. has a 50% trademark registration rate, with 6 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.